ConductScience.org, home

Paper6337705

Generation of monoclonal antibodies reacting with normal and cancer cells of human breast.

Mènard S and 4 others. Cancer Res, 1983. Cited by 204 papers, by iCite.

Cite this record

ConductScience Library. Generation of monoclonal antibodies reacting with normal and cancer cells of human breast. Papers, record 6337705. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6337705

Download JSON
Cell line
MBr13 papers
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Generation of monoclonal antibodies reacting with normal and cancer cells of human breast.
PubMed
Journal
Cancer Res
PubMed
Year
1983
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
204
iCite
Relative citation ratio, by iCite
5.89
iCite
Revised in PubMed
2006-11-15
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mènard SS
2Tagliabue EE
3Canevari SS
4Fossati GG
5Colnaghi MIM I

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, MonoclonalMajor topic
BreastMajor topic
Breast NeoplasmsMajor topic
Animals
Cell Line
Female
Fluorescent Antibody Technique
Humans
Mice
Mice, Inbred BALB C
Multiple Myeloma
Substrate Specificity

Source PubMed

Download CSV of topics

Cited by57

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 204 citations.

PMIDTitleJournalYearIn PapersSource
41799195Globo H ceramide confers chemoresistance and poor prognosis to advanced gallbladder cancer via A2AR/cAMP/PKA pathway.Theranostics2026https://conductscience.org/library/papers/41799195PubMed
40589148Blood group O expression in normal tissues and tumors.FEBS J2025https://conductscience.org/library/papers/40589148PubMed
39311947Phase I-II study of OBI-888, a humanized monoclonal IgG1 antibody against the tumor-associated carbohydrate antigen Globo H, in patients with advanced solid tumors.Cancer Chemother Pharmacol2024https://conductscience.org/library/papers/39311947PubMed
38305761Serum antibody screening using glycan arrays.Chem Soc Rev2024https://conductscience.org/library/papers/38305761PubMed
36174107Glycoconjugates: Synthesis, Functional Studies, and Therapeutic Developments.Chem Rev2022https://conductscience.org/library/papers/36174107PubMed
35282679Selective Recognition of Carbohydrate Antigens by Germline Antibodies Isolated from AID Knockout Mice.J Am Chem Soc2022https://conductscience.org/library/papers/35282679PubMed
35106375Synthesis of Azido-Globo H Analogs for Immunogenicity Evaluation.ACS Cent Sci2022https://conductscience.org/library/papers/35106375PubMed
33917390Application of the Antibody-Inducing Activity of Glycosphingolipids to Human Diseases.Int J Mol Sci2021https://conductscience.org/library/papers/33917390PubMed
32893977Targeting UDP-glucose dehydrogenase inhibits ovarian cancer growth and metastasis.J Cell Mol Med2020https://conductscience.org/library/papers/32893977PubMed
29036791Globo H expression is associated with driver mutations and PD-L1 expressions in stage I non-small cell lung cancer.Cancer Biomark2017https://conductscience.org/library/papers/29036791PubMed
28187738Naturally occurring anti-glycan antibodies binding to Globo H-expressing cells identify ovarian cancer patients.J Ovarian Res2017https://conductscience.org/library/papers/28187738PubMed
26918109A Fully Synthetic Self-Adjuvanting Globo H-Based Vaccine Elicited Strong T Cell-Mediated Antitumor Immunity.Chem Sci2015https://conductscience.org/library/papers/26918109PubMed
26257889Chemical Synthesis of the Tumor-Associated Globo H Antigen.RSC Adv2015https://conductscience.org/library/papers/26257889PubMed
23908400Immunization of fucose-containing polysaccharides from Reishi mushroom induces antibodies to tumor-associated Globo H-series epitopes.Proc Natl Acad Sci U S A2013https://conductscience.org/library/papers/23908400PubMed
23355685Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancer.Proc Natl Acad Sci U S A2013https://conductscience.org/library/papers/23355685PubMed
21964054Cancer vaccines and carbohydrate epitopes.Vaccine2011https://conductscience.org/library/papers/21964054PubMed
21423783Synthesis of Human Cancer Associated Globo-H (MBr1) Glycosylamino Acid: Some Mechanistic and Conformational Reinvestigations.Heterocycles2009https://conductscience.org/library/papers/21423783PubMed
21415121A method for visualization of "omic" datasets for sphingolipid metabolism to predict potentially interesting differences.J Lipid Res2011https://conductscience.org/library/papers/21415121PubMed
19874068A practical total synthesis of globo-H for use in anticancer vaccines.J Org Chem2009https://conductscience.org/library/papers/19874068PubMed
19724783Immunotherapy for cancer: synthetic carbohydrate-based vaccines.Chem Commun (Camb)2009https://conductscience.org/library/papers/19724783PubMed

See all 57 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6337705

GET https://conductscience.org/api/papers/v1/6337705/cited_by?page=2